{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:19:58Z","timestamp":1777389598859,"version":"3.51.4"},"reference-count":51,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013129","name":"Ministry of SMEs and Startups","doi-asserted-by":"publisher","award":["S2519744"],"award-info":[{"award-number":["S2519744"]}],"id":[{"id":"10.13039\/501100013129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gyeonggi Province","award":["D191972"],"award-info":[{"award-number":["D191972"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cell-penetrating peptides (CPPs) are defined by their ability to deliver cargo into cells and have been studied and developed as a promising drug-delivery system (DDS). However, the issue of whether the CPPs that have already entered the cells can be re-released or reused has not been studied. The purpose of this research was to construct CPP-conjugated human fibroblast growth factor 2 (hFGF2) and investigate whether they can be re-released from the cell membrane for reuse. This study combined hFGF2 with Tat or Ara27, a newly developed CPP derived from the zinc knuckle (CCHC-type) family protein of Arabidopsis. Human dermal fibroblast (HDF) was treated with Tat-conjugated hFGF2 (tFGF2) and Ara27-conjugated hFGF2 (NR-FGF2) for both long and short durations, and the effects on cell growth were compared. Furthermore, tFGF2 and NR-FGF2 re-released from the cells were quantified and the effects were evaluated by culturing HDF in a conditioned medium. Interestingly, the proliferation of HDF increased only when NR-FGF2 was treated for 1 h in endocytosis-independent manner. After 1 h, NR-FGF2 was significantly re-released, reaching a maximum concentration at 5 h. Furthermore, increased proliferation of HDF cultured in the conditioned medium containing re-released NR-FGF2 was discovered. While previous studies have focused on the delivery of cargo and its associated applications, this study has revealed that combinations of superior CPPs and therapeutics can be expected to prolong both the retention time and the cell-penetrating capacity, even in the presence of external factors. Therefore, CPPs can be applied in the context of topical drugs and cosmetics as a new DDS approach.<\/jats:p>","DOI":"10.3390\/ijms21020442","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T04:06:51Z","timestamp":1578629211000},"page":"442","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cell-Penetrating Peptides Enhance the Activity of Human Fibroblast Growth Factor 2 by Prolonging the Retention Time: A New Vision for Drug-Delivery Systems"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-3845","authenticated-orcid":false,"given":"Jaehoon","family":"Lee","sequence":"first","affiliation":[{"name":"Biomedical Research Institute, NeoRegen Biotech Co., Ltd., Gyeonggi-do 16614, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mijin","family":"Kwon","sequence":"additional","affiliation":[{"name":"Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, Seoul National University School of Dentistry, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeun","family":"Oh","sequence":"additional","affiliation":[{"name":"Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, Seoul National University School of Dentistry, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaehyun","family":"Park","sequence":"additional","affiliation":[{"name":"Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, Seoul National University School of Dentistry, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangkyu","family":"Park","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, NeoRegen Biotech Co., Ltd., Gyeonggi-do 16614, Korea"},{"name":"Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, Seoul National University School of Dentistry, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeongmin","family":"Seo","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, NeoRegen Biotech Co., Ltd., Gyeonggi-do 16614, Korea"},{"name":"Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, Seoul National University School of Dentistry, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8082-6459","authenticated-orcid":false,"given":"Sangho","family":"Roh","sequence":"additional","affiliation":[{"name":"Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, Seoul National University School of Dentistry, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2016.06.002","article-title":"Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges","volume":"110","author":"Komin","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/ab500179h","article-title":"Design strategies and applications of circulating cell-mediated drug delivery systems","volume":"1","author":"Su","year":"2015","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s12272-010-0311-5","article-title":"Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein","volume":"33","author":"Yoo","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.colsurfb.2009.08.013","article-title":"Mathematical description of drug movement into tumor with EPR effect and estimation of its configuration for DDS","volume":"75","author":"Hara","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1016\/j.biomaterials.2011.07.004","article-title":"Aptamer-functionalized PEG\u2013PLGA nanoparticles for enhanced anti-glioma drug delivery","volume":"32","author":"Guo","year":"2011","journal-title":"Biomaterials"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1126\/science.1095833","article-title":"Drug delivery systems: Entering the mainstream","volume":"303","author":"Allen","year":"2004","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0092-8674(88)90262-0","article-title":"Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein","volume":"55","author":"Green","year":"1988","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1126\/science.2556795","article-title":"Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1","volume":"246","author":"Viscidi","year":"1989","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.addr.2009.04.005","article-title":"Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape","volume":"61","author":"Endoh","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.coph.2006.04.004","article-title":"Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery","volume":"6","author":"Langel","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","article-title":"Twenty years of cell-penetrating peptides: From molecular mechanisms to therapeutics","volume":"157","author":"Heitz","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-60761-919-2_24","article-title":"PTD\u2013DRBD siRNA Delivery","volume":"Volume 683","author":"Eguchi","year":"2011","journal-title":"Cell-Penetrating Peptides"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Santra, S., Yang, H., Stanley, J.T., Holloway, P.H., Moudgil, B.M., Walter, G., and Mericle, R.A. (2005). Rapid and effective labeling of brain tissue using TAT-conjugated CdS: Mn\/ZnS quantum dots. Chem. Commun. (Camb.), 3144\u20133146.","DOI":"10.1039\/b503234b"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1166\/jnn.2018.14864","article-title":"Construction and characterization of cell-penetrating peptide-fused fibroblast growth factor and vascular endothelial growth factor for an enhanced percutaneous delivery system","volume":"18","author":"Choi","year":"2018","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/15384047.2016.1156266","article-title":"A specific aptamer-cell penetrating peptides complex delivered siRNA efficiently and suppressed prostate tumor growth in vivo","volume":"17","author":"Diao","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1096\/fasebj.2019.33.1_supplement.620.5","article-title":"Simultaneous delivery of CRISPR\/Cas and donor DNA using cell-penetrating peptide-adaptors","volume":"33","author":"Mbugua","year":"2019","journal-title":"FASEB J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/jop.2014.0019","article-title":"Subconjunctival injection of XG-102, a c-Jun N-Terminal Kinase inhibitor peptide, in the treatment of endotoxin-induced uveitis in rats","volume":"31","author":"Touchard","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/bjc.2013.74","article-title":"A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours","volume":"108","author":"Warso","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e00020","DOI":"10.1002\/prp2.20","article-title":"XG-102 administered to healthy male volunteers as a single intravenous infusion: A randomized, double-blind, placebo-controlled, dose-escalating study","volume":"2","author":"Deloche","year":"2014","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/ph6010032","article-title":"The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders","volume":"6","author":"Papadopoulou","year":"2013","journal-title":"Pharmaceuticals"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1038\/srep04900","article-title":"The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: Novel activatable forms of Xentry","volume":"4","author":"Montrose","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.tibs.2015.10.004","article-title":"Mechanism matters: A taxonomy of cell penetrating peptides","volume":"40","author":"Kauffman","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"29974","DOI":"10.1074\/jbc.M113.488312","article-title":"Direct cytosolic delivery of polar cargo to cells by spontaneous membrane-translocating peptides","volume":"288","author":"He","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/BJ20150272","article-title":"Efficient entry of cell-penetrating peptide nona-arginine into adherent cells involves a transient increase in intracellular calcium","volume":"471","author":"Melikov","year":"2015","journal-title":"Biochem. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/1061186X.2018.1491978","article-title":"Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles","volume":"27","author":"Fathi","year":"2019","journal-title":"J. Drug Target."},{"key":"ref_27","first-page":"3032158","article-title":"Delivery of miRNA-29b using R9-LK15, a novel cell-penetrating peptide, promotes osteogenic differentiation of bone mesenchymal stem cells","volume":"2019","author":"Liu","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1038\/s41598-019-42456-8","article-title":"Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines","volume":"9","author":"Patel","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00018-009-0186-0","article-title":"Cell penetrating peptides: Overview and applications to the delivery of oligonucleotides","volume":"67","author":"Hassane","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1367-5931(99)80016-7","article-title":"Noninvasive intracellular delivery of functional peptides and proteins","volume":"3","author":"Hawiger","year":"1999","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm1269","article-title":"Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis","volume":"11","author":"Jo","year":"2005","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/ten.teb.2018.0350","article-title":"Regenerative scar-free skin wound healing","volume":"25","author":"Monavarian","year":"2019","journal-title":"Tissue Eng. Part B Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000454919","article-title":"Skin wound healing: An update on the current knowledge and concepts","volume":"58","author":"Sorg","year":"2017","journal-title":"Eur. Surg. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13287-017-0549-7","article-title":"Basic fibroblast growth factor reduces scar by inhibiting the differentiation of epidermal stem cells to myofibroblasts via the Notch1\/Jagged1 pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.biomaterials.2012.09.055","article-title":"The use of native chemical functional groups presented by wound beds for the covalent attachment of polymeric microcarriers of bioactive factors","volume":"34","author":"Jain","year":"2013","journal-title":"Biomaterials"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ki.2011.77","article-title":"Scar wars: Mapping the fate of epithelial\u2013mesenchymal\u2013myofibroblast transition","volume":"80","author":"Quaggin","year":"2011","journal-title":"Kidney Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1016\/j.biomaterials.2012.07.061","article-title":"The effect of epidermal growth factor (EGF) conjugated with low-molecular-weight protamine (LMWP) on wound healing of the skin","volume":"33","author":"Choi","year":"2012","journal-title":"Biomaterials"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2133.2009.09581.x","article-title":"Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1\/2 and JNK pathways","volume":"162","author":"Makino","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.bbamem.2007.03.029","article-title":"Peptide degradation is a critical determinant for cell-penetrating peptide uptake","volume":"1768","author":"Palm","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1021\/ja7102026","article-title":"Real-time fluorescence detection of protein transduction into live cells","volume":"130","author":"Lee","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.7150\/ntno.18292","article-title":"Heparin-regulated prodrug-type macromolecular theranostic systems for cancer therapy","volume":"1","author":"Wang","year":"2017","journal-title":"Nanotheranostics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1021\/acs.biomac.6b00398","article-title":"Heparin-based coacervate of FGF2 improves dermal regeneration by asserting a synergistic role with cell proliferation and endogenous facilitated VEGF for cutaneous wound healing","volume":"17","author":"Wu","year":"2016","journal-title":"Biomacromolecules"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2004.10.018","article-title":"Cationic TAT peptide transduction domain enters cells by macropinocytosis","volume":"102","author":"Kaplan","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1600-0854.2007.00572.x","article-title":"A comprehensive model for the cellular uptake of cationic cell-penetrating peptides","volume":"8","author":"Duchardt","year":"2007","journal-title":"Traffic"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chembiol.2012.05.022","article-title":"Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm","volume":"19","author":"Appelbaum","year":"2012","journal-title":"Chem. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0005-2736(01)00398-4","article-title":"Cargo delivery kinetics of cell-penetrating peptides","volume":"1515","author":"Elmquist","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_47","first-page":"194","article-title":"Translocation mechanism(s) of cell-penetrating peptides: Biophysical studies using artificial membrane bilayers","volume":"54","author":"Chassaing","year":"2014","journal-title":"Biochemistry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.bbamem.2009.05.001","article-title":"Lipid reorganization induced by membrane-active peptides probed using differential scanning calorimetry","volume":"1788","author":"Joanne","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2174\/138920312804142174","article-title":"Is there anybody in there? On the mechanisms of wall crossing of cell penetrating peptides","volume":"13","author":"Walrant","year":"2012","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","article-title":"Cell-penetrating peptides: Classes, origin, and current landscape","volume":"17","author":"Milletti","year":"2012","journal-title":"Drug Discov. Today"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/pro.256","article-title":"MPEx: A tool for exploring membrane proteins","volume":"18","author":"Snider","year":"2009","journal-title":"Protein Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/2\/442\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:19:24Z","timestamp":1760361564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/2\/442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["ijms21020442"],"URL":"https:\/\/doi.org\/10.3390\/ijms21020442","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]}}}